AUTLAutolus Therapeutics plc
$1.54-0.97% 1Y
$1.54
$1.2152 weeks$2.54
Is the price fair?
What AUTL's price assumes
Autolus Therapeutics plc did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 3.62× revenue.
3.62
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 5.67
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 5.67
- EV / EBIToperating margin −211%: the multiple describes the denominator
- not meaningful
- Market capitalisation266.2 million shares, counted Aug 10, 2026
- $409M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.